Oncimmune and Biodesix Form Strategic Partnership to Unlock Full Potential of EarlyCDT® Lung in US Life Science
NMPA Accepts New Drug Application for IBI301, a Biosimilar Product Candidate of Rituximab (MabThera/Rituxan) Life Science
Johnson & Johnson Opens JLABS @ Shanghai, a Life Science Incubator with 31 Resident Startups Life Science